56 related articles for article (PubMed ID: 1354257)
1. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
[TBL] [Abstract][Full Text] [Related]
2. The dopamine D1-D2 receptor heteromer exerts a tonic inhibitory effect on the expression of amphetamine-induced locomotor sensitization.
Shen MY; Perreault ML; Fan T; George SR
Pharmacol Biochem Behav; 2015 Jan; 128():33-40. PubMed ID: 25444866
[TBL] [Abstract][Full Text] [Related]
3. c-Fos expression by dopaminergic receptor activation in rat hippocampal neurons.
Kang DK; Kim KO; Lee SH; Lee YS; Son H
Mol Cells; 2000 Oct; 10(5):546-51. PubMed ID: 11101146
[TBL] [Abstract][Full Text] [Related]
4. Nitro-l-arginine attenuates SKF 38393-induced oral activity in neonatal 6-hydroxydopamine-lesioned rats.
Brus R; Szkilnik R; Nowak P; Kostrzewa RM
Acta Neurobiol Exp (Wars); 1997; 57(4):283-7. PubMed ID: 9519546
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic regulation of sleep and cataplexy in a murine model of narcolepsy.
Burgess CR; Tse G; Gillis L; Peever JH
Sleep; 2010 Oct; 33(10):1295-304. PubMed ID: 21061851
[TBL] [Abstract][Full Text] [Related]
6. Rotation and immediate-early gene expression in rats treated with the atypical D1 dopamine agonist SKF 83822.
Wirtshafter D
Pharmacol Biochem Behav; 2007 Mar; 86(3):505-10. PubMed ID: 17306871
[TBL] [Abstract][Full Text] [Related]
7. Allosteric modulation of sigma-1 receptors elicits anti-seizure activities.
Guo L; Chen Y; Zhao R; Wang G; Friedman E; Zhang A; Zhen X
Br J Pharmacol; 2015 Aug; 172(16):4052-65. PubMed ID: 25989224
[TBL] [Abstract][Full Text] [Related]
8. Opioid regulation of Pavlovian overshadowing in fear conditioning.
Zelikowsky M; Fanselow MS
Behav Neurosci; 2010 Aug; 124(4):510-9. PubMed ID: 20695650
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the dopaminergic system in the reward-related behavior of pregabalin.
Althobaiti YS; Almutairi FM; Alshehri FS; Altowairqi E; Marghalani AM; Alghorabi AA; Alsanie WF; Gaber A; Alsaab HO; Almalki AH; Hakami AY; Alkhalifa T; Almalki AD; Hardy AMG; Shah ZA
Sci Rep; 2021 May; 11(1):10577. PubMed ID: 34011976
[TBL] [Abstract][Full Text] [Related]
10. A dopamine D1-like receptor-specific agonist improves the survival of septic mice.
Tanaka K; Choudhury ME; Kikuchi S; Takeda I; Umakoshi K; Miyaue N; Mikami K; Takenaga A; Yagi H; Shinabe R; Matsumoto H; Yano H; Nagai M; Takeba J; Tanaka J
iScience; 2024 Apr; 27(4):109587. PubMed ID: 38623339
[TBL] [Abstract][Full Text] [Related]
11. Autocrine activation of neuronal NMDA receptors by aspartate mediates dopamine- and cAMP-induced CREB-dependent gene transcription.
Almeida LE; Murray PD; Zielke HR; Roby CD; Kingsbury TJ; Krueger BK
J Neurosci; 2009 Oct; 29(40):12702-10. PubMed ID: 19812345
[TBL] [Abstract][Full Text] [Related]
12. Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva).
Ray AP; Chebolu S; Darmani NA
Pharmacol Biochem Behav; 2009 Nov; 94(1):211-8. PubMed ID: 19699757
[TBL] [Abstract][Full Text] [Related]
13. Dopamine receptor supersensitivity: development, mechanisms, presentation, and clinical applicability.
Kostrzewa RM; Kostrzewa JP; Brown RW; Nowak P; Brus R
Neurotox Res; 2008 Oct; 14(2-3):121-8. PubMed ID: 19073420
[TBL] [Abstract][Full Text] [Related]
14. Changes in apical dendritic structure correlate with sustained ERK1/2 phosphorylation in medial prefrontal cortex of a rat model of dopamine D1 receptor agonist sensitization.
Papadeas ST; Halloran C; McCown TJ; Breese GR; Blake BL
J Comp Neurol; 2008 Nov; 511(2):271-85. PubMed ID: 18785628
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological models of ADHD.
Kostrzewa RM; Kostrzewa JP; Kostrzewa RA; Nowak P; Brus R
J Neural Transm (Vienna); 2008; 115(2):287-98. PubMed ID: 17994186
[TBL] [Abstract][Full Text] [Related]
16. Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptors.
Ryman-Rasmussen JP; Griffith A; Oloff S; Vaidehi N; Brown JT; Goddard WA; Mailman RB
Neuropharmacology; 2007 Feb; 52(2):562-75. PubMed ID: 17067639
[TBL] [Abstract][Full Text] [Related]
17. Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement.
Papadeas ST; Blake BL; Knapp DJ; Breese GR
J Neurosci; 2004 Jun; 24(26):5863-76. PubMed ID: 15229233
[TBL] [Abstract][Full Text] [Related]
18. Dopamine receptor supersensitivity: an outcome and index of neurotoxicity.
Kostrzewa RM; Kostrzewa JP; Brus R
Neurotox Res; 2003; 5(1-2):111-8. PubMed ID: 12832226
[TBL] [Abstract][Full Text] [Related]
19. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area.
Bontempi B; Sharp FR
J Neurosci; 1997 Nov; 17(21):8596-612. PubMed ID: 9334431
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
